Press release
Global Colorectal Cancer Therapeutics Industry Size,Chain Research Report 2022-2028|Taiho Pharma, Merck KGaA, Amgen
Los Angeles, United States October 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Colorectal Cancer Therapeutics market. It sheds light on how the global Colorectal Cancer Therapeutics market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Colorectal Cancer Therapeutics market and the different players operating therein. The authors of the report have also provided qualitative and quantitative analyses of several microeconomic and macroeconomic factors impacting the global Colorectal Cancer Therapeutics market. In addition, the research study helps to understand the changes in the industry supply chain, manufacturing process and cost, sales scenarios, and dynamics of the global Colorectal Cancer Therapeutics market.
Get a PDF template of this report:
https://www.qyresearch.com/sample-form/form/5087181/Global-Colorectal-Cancer-Therapeutics-Industry-Research-Report-Growth-Trends-and-Competitive-Analysis-2022-2028
Each player studied in the report is profiled while taking into account its production, market value, sales, gross margin, market share, recent developments, and marketing and business strategies. Besides giving a broad study of the drivers, restraints, trends, and opportunities of the global Colorectal Cancer Therapeutics market, the report offers an individual, detailed analysis of important regions such as North America, Europe, and Asia Pacific. Furthermore, important segments of the global Colorectal Cancer Therapeutics market are studied in great detail with key focus on their market share, CAGR, and other vital factors.
Key Players:
Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Hutchison MediPharma, Jiangsu Hengrui Medicine, Jiangsu Chia-Tai Tianqing, Suzhou Zelgen Biopharmaceuticals
Type Segments:
Diagnostics, Therapeutics
Application Segments:
Hospitals, Clinic, Research Institutions
Some Important points covered in Report:
Industry Overview: The first section of the research study touches on an overview of the global Colorectal Cancer Therapeutics market, market status and outlook, and product scope. Additionally, it provides highlights of key segments of the global Colorectal Cancer Therapeutics market, i.e. regional, type, and application segments.
Competition Analysis: Here, the report brings to light important mergers and acquisitions, business expansions, product or service differences, market concentration rate, the competitive status of the global Colorectal Cancer Therapeutics market, and market size by player.
Company Profiles and Key Data: This section deals with the company profiling of leading players of the global Colorectal Cancer Therapeutics market on the basis of revenue, products, business, and other factors mentioned earlier.
Market Size by Type and Application: Besides offering a deep analysis of the size of the global Colorectal Cancer Therapeutics market by type and application, this section provides a study on top end users or consumers and potential applications.
North America Market: Here, the report explains the changes in the market size of North America by application and player.
Europe Market: This section of the report shows how the size of the Europe market will change in the next few years.
China Market: It gives an analysis of the China market and its size for all the years of the forecast period.
Rest of Asia Pacific Market: The Rest of the Asia Pacific market is analyzed in quite some detail here on the basis of application and player.
Central and South America Market: The report explains the changes in the size of the Central and South America market by player and application.
MEA Market: This section shows how the size of the MEA market will change during the course of the forecast period.
Market Dynamics: Here, the report deals with the drivers, restraints, challenges, trends, and opportunities of the global Colorectal Cancer Therapeutics market. This section also includes the Porter's Five Forces analysis.
Research Findings and Conclusion: It gives powerful recommendations for new as well as established players for securing a position of strength in the global Colorectal Cancer Therapeutics market.
Methodology and Data Source: This section includes the author's list, a disclaimer, a research approach, and data sources.
Key Questions Answered
What will be the size and CAGR of the global Colorectal Cancer Therapeutics market in the next five years?
Which segment will take the lead in the global Colorectal Cancer Therapeutics market?
What does the average manufacturing cost?
What are the key business tactics adopted by top players of the global Colorectal Cancer Therapeutics market?
Which region will secure a lion's share of the global Colorectal Cancer Therapeutics market?
Which company will show dominance in the global Colorectal Cancer Therapeutics market?
Research Methodology
QY Research uses trustworthy primary and secondary research sources to compile its reports. It also relies on the latest research techniques to prepare highly detailed and accurate research studies such as this one here. It uses data triangulation, top-down and bottom-up approaches, and advanced research processes to come out with comprehensive and industry-best market research reports.
Request for customization in Report :
https://www.qyresearch.com/customize-request/form/5087181/Global-Colorectal-Cancer-Therapeutics-Industry-Research-Report-Growth-Trends-and-Competitive-Analysis-2022-2028
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Colorectal Cancer Therapeutics Market Size (2017-2028)
2.2 Colorectal Cancer Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Colorectal Cancer Therapeutics Market Size by Region (2017-2022)
2.4 Global Colorectal Cancer Therapeutics Market Size Forecast by Region (2023-2028)
2.5 Global Top Colorectal Cancer Therapeutics Countries Ranking by Market Size
3 Colorectal Cancer Therapeutics Competitive by Company
3.1 Global Colorectal Cancer Therapeutics Revenue by Players
3.1.1 Global Colorectal Cancer Therapeutics Revenue by Players (2017-2022)
3.1.2 Global Colorectal Cancer Therapeutics Market Share by Players (2017-2022)
3.2 Global Colorectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Colorectal Cancer Therapeutics Revenue
3.4 Global Colorectal Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Therapeutics Revenue in 2021
3.5 Global Colorectal Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Colorectal Cancer Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Therapeutics Historic Revenue by Type (2017-2022)
4.2 Global Colorectal Cancer Therapeutics Forecasted Revenue by Type (2023-2028)
5 Global Colorectal Cancer Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Colorectal Cancer Therapeutics Revenue by Company (2020-2022)
6.2 North America Colorectal Cancer Therapeutics Revenue by Type (2017-2028)
6.3 North America Colorectal Cancer Therapeutics Revenue by Application (2017-2028)
6.4 North America Colorectal Cancer Therapeutics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Colorectal Cancer Therapeutics Revenue by Company (2020-2022)
7.2 Europe Colorectal Cancer Therapeutics Revenue by Type (2017-2028)
7.3 Europe Colorectal Cancer Therapeutics Revenue by Application (2017-2028)
7.4 Europe Colorectal Cancer Therapeutics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Colorectal Cancer Therapeutics Revenue by Company (2020-2022)
8.2 Asia Pacific Colorectal Cancer Therapeutics Revenue by Type (2017-2028)
8.3 Asia Pacific Colorectal Cancer Therapeutics Revenue by Application (2017-2028)
8.4 Asia Pacific Colorectal Cancer Therapeutics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Colorectal Cancer Therapeutics Revenue by Company (2020-2022)
9.2 Latin America Colorectal Cancer Therapeutics Revenue by Type (2017-2028)
9.3 Latin America Colorectal Cancer Therapeutics Revenue by Application (2017-2028)
9.4 Latin America Colorectal Cancer Therapeutics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Colorectal Cancer Therapeutics Revenue by Company (2020-2022)
10.2 Middle East and Africa Colorectal Cancer Therapeutics Revenue by Type (2017-2028)
10.3 Middle East and Africa Colorectal Cancer Therapeutics Revenue by Application (2017-2028)
10.4 Middle East and Africa Colorectal Cancer Therapeutics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Taiho Pharma
11.1.1 Taiho Pharma Company Details
11.1.2 Taiho Pharma Business Overview
11.1.3 Taiho Pharma Colorectal Cancer Therapeutics Products and Services
11.1.4 Taiho Pharma Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.1.5 Taiho Pharma Colorectal Cancer Therapeutics SWOT Analysis
11.1.6 Taiho Pharma Recent Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Colorectal Cancer Therapeutics Products and Services
11.2.4 Merck KGaA Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.2.5 Merck KGaA Colorectal Cancer Therapeutics SWOT Analysis
11.2.6 Merck KGaA Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Colorectal Cancer Therapeutics Products and Services
11.3.4 Amgen Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.3.5 Amgen Colorectal Cancer Therapeutics SWOT Analysis
11.3.6 Amgen Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Colorectal Cancer Therapeutics Products and Services
11.4.4 Takeda Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.4.5 Takeda Colorectal Cancer Therapeutics SWOT Analysis
11.4.6 Takeda Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Colorectal Cancer Therapeutics Products and Services
11.5.4 Roche Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.5.5 Roche Colorectal Cancer Therapeutics SWOT Analysis
11.5.6 Roche Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Colorectal Cancer Therapeutics Products and Services
11.6.4 Eli Lilly Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.6.5 Eli Lilly Colorectal Cancer Therapeutics SWOT Analysis
11.6.6 Eli Lilly Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Colorectal Cancer Therapeutics Products and Services
11.7.4 Sanofi Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.7.5 Sanofi Colorectal Cancer Therapeutics SWOT Analysis
11.7.6 Sanofi Recent Developments
11.8 Regeneron
11.8.1 Regeneron Company Details
11.8.2 Regeneron Business Overview
11.8.3 Regeneron Colorectal Cancer Therapeutics Products and Services
11.8.4 Regeneron Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.8.5 Regeneron Colorectal Cancer Therapeutics SWOT Analysis
11.8.6 Regeneron Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Colorectal Cancer Therapeutics Products and Services
11.9.4 Bayer Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.9.5 Bayer Colorectal Cancer Therapeutics SWOT Analysis
11.9.6 Bayer Recent Developments
11.10 Onyx
11.10.1 Onyx Company Details
11.10.2 Onyx Business Overview
11.10.3 Onyx Colorectal Cancer Therapeutics Products and Services
11.10.4 Onyx Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.10.5 Onyx Colorectal Cancer Therapeutics SWOT Analysis
11.10.6 Onyx Recent Developments
11.11 Bristol-Myers Squib
11.11.1 Bristol-Myers Squib Company Details
11.11.2 Bristol-Myers Squib Business Overview
11.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Products and Services
11.11.4 Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.11.5 Bristol-Myers Squib Recent Developments
11.12 Sumitomo Dainippon Pharma
11.12.1 Sumitomo Dainippon Pharma Company Details
11.12.2 Sumitomo Dainippon Pharma Business Overview
11.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Products and Services
11.12.4 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.12.5 Sumitomo Dainippon Pharma Recent Developments
11.13 Array BioPharma
11.13.1 Array BioPharma Company Details
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Colorectal Cancer Therapeutics Products and Services
11.13.4 Array BioPharma Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.13.5 Array BioPharma Recent Developments
11.14 Hutchison MediPharma
11.14.1 Hutchison MediPharma Company Details
11.14.2 Hutchison MediPharma Business Overview
11.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Products and Services
11.14.4 Hutchison MediPharma Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.14.5 Hutchison MediPharma Recent Developments
11.15 Jiangsu Hengrui Medicine
11.15.1 Jiangsu Hengrui Medicine Company Details
11.15.2 Jiangsu Hengrui Medicine Business Overview
11.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Products and Services
11.15.4 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.15.5 Jiangsu Hengrui Medicine Recent Developments
11.16 Jiangsu Chia-Tai Tianqing
11.16.1 Jiangsu Chia-Tai Tianqing Company Details
11.16.2 Jiangsu Chia-Tai Tianqing Business Overview
11.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Products and Services
11.16.4 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.16.5 Jiangsu Chia-Tai Tianqing Recent Developments
11.17 Suzhou Zelgen Biopharmaceuticals
11.17.1 Suzhou Zelgen Biopharmaceuticals Company Details
11.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Products and Services
11.17.4 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue in Colorectal Cancer Therapeutics Business (2017-2022)
11.17.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
12 Colorectal Cancer Therapeutics Market Dynamics
12.1 Colorectal Cancer Therapeutics Market Trends
12.2 Colorectal Cancer Therapeutics Market Drivers
12.3 Colorectal Cancer Therapeutics Market Challenges
12.4 Colorectal Cancer Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
+1 626 539 9760 / +91 8669986909
hitesh@qyresearch.com / enquiry@qyresearch.com"
About Us
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Colorectal Cancer Therapeutics Industry Size,Chain Research Report 2022-2028|Taiho Pharma, Merck KGaA, Amgen here
News-ID: 2772704 • Views: …
More Releases from QY Research, Inc
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder…
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid
The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow…
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, …
A strain gauge (or strain gage) is a sensor whose resistance varies with applied force; it converts force, pressure, tension, weight, etc., into a change in electrical resistance which can then be measured. When external forces are applied to a stationary object, stress and strain are the result. Stress is defined as the object"s internal Strain Gauge forces, and strain is defined as the displacement and deformation that occur.
The global…
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Project …
Automatic soap dispensers (also known as touchless or no-touch soap dispensers) dispense a controlled amount of soap solution (or a similar liquid such as a hand sanitizer). They are often used in conjunction with automatic faucets in public restrooms. They function to conserve the amount of soap used and stem infectious disease transmission.
The global Automatic Soap Dispensers market was valued at US$ million in 2023 and is anticipated to reach…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
